Alkhouri et al reported an algorithm for identifying a pediatric patient with nonalcoholic fatty liver disease (NAFLD) with hepatic fibrosis. This relies on 2 noninvasive tests to triage the patient based on risk. The authors are from the Cleveland Clinic, University College London, the University of Florence, Liver Research Unit in Trieste, the University of Milan, Ospedale Maggiore Policlinico in Milan and Bambino Gesu Children’s Hospital in Rome.
